Emfizatamab Antibody
Emfizatamab (GNC-038) is a tetravalent bispecific antibody engaging CD3 and 4-1BB on T cells and targeting CD19/PD-L1 on tumor cells, inducing T-cell cytotoxicity. It is utilized in leukemia and lymphoma research, with studies demonstrating its antitumor activity in both in vitro assays and in vivo xenograft models.
Product Specifications
Target
TNF, PD-1/PD-L1, Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
